eFFECTOR Therapeutics, Inc.

United States of America


 
Total IP 69
Total IP Rank # 19,490
IP Activity Score 2.5/5.0    42
IP Activity Rank # 17,702
Stock Symbol
ISIN US28202V1089
Market Cap. 0.001M  (USD)
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

28 3
12 2
22 1
1
 
Last Patent 2024 - Solid forms of an eif4e inhibitor
First Patent 2015 - Compositions and methods for tre...
Last Trademark 2023 - EFFECTOR
First Trademark 2012 - EFFECTOR THERAPEUTICS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2023 G/S Medical research; providing medical and scientific research information in the field of pharmaceu...
Invention Eif4a-inhibiting compounds and methods related thereto. The present invention provides synthesis...
Invention Methods and compositions for cellular immunotherapy. The present disclosure relates to genetical...
2022 Invention Eif4e-inhibiting compounds and methods. The present invention provides synthesis, pharmaceutical...
2021 Invention Solid forms of an eif4e inhibitor. The present invention relates to solid forms of 7-(5-chloro-2...
Invention Solid forms of an eif4e inhibitor. The present invention relates to solid forms of 7-(5-chloro-2-...
Invention Crystalline forms of mnk inhibitors. The present invention provides crystalline solids of 6′-((6-...
Invention Piperidine-substituted mnk inhibitors and methods related thereto. The present invention relates ...
Invention Covalent modifiers of eif4e inhibiting compounds. The present invention is directed to novel tran...
Invention Mnk inhibitors and methods related thereto. The present invention relates to compounds according...
Invention Eif4a inhibitor combinations. The present disclosure relates to methods for ameliorating or treat...
Invention Eif4a inhibitor combinations. The present disclosure relates to methods for ameliorating or trea...
2020 Invention Methods and compositions for cellular immunotherapy. The present disclosure relates to geneticall...
Invention Methods of treating braf-mutated cancer cells. The present disclosure provides methods for the t...
Invention Eif4e-inhibiting compounds and methods. The present invention provides synthesis, pharmaceuticall...
Invention Eif4e-inhibiting 4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine compounds. The present invention provid...
Invention Methods of treating braf-mutated cancer cells. The present disclosure provides methods for the tr...
Invention Eif4e inhibitors for use as immune checkpoint modulators and related methods. The present disclos...
Invention Translational enhancers and related methods. e.ge.g., mRNAs) comprising the novel translational e...
Invention Translation inhibitors and uses thereof. The present disclosure provides compositions comprising ...
Invention Inhibitors of immune checkpoint modulators and related methods. The present disclosure relates t...
Invention Mnk biomarkers and uses thereof. The present disclosure relates to compositions and methods for ...
Invention Eif4a-inhibiting compounds and methods related thereto. The present invention provides synthesis,...
2019 Invention Crystalline forms of mnk inhibitors. Hαα]pyridine]-1,5'-dione: The crystalline compounds of the p...
Invention Crystalline forms of mnk inhibitors. The present invention provides crystalline solids of 6'-((6-...
Invention Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit mnk1 and mnk2. The pr...
2018 Invention Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of mnk1 and mnk2. ...
Invention Benzimidazole-indole inhibitors of mnk1 and mnk2. The present invention provides synthesis, pharm...
Invention Use of translational profiling to identify target molecules for therapeutic treatment. The prese...
Invention Compositions and methods for an improved antitumor immune response. The present disclosure provid...
Invention Compositions and methods for treating fibrotic disease. The present disclosure relates to composi...
Invention Piperidine-substituted mnk inhibitors and methods related thereto. The present invention relates...
2016 G/S medical research; providing medical testing services and information in the field of cancer resea...
G/S Therapeutic agents for acting on protein targets that selectively regulate translational control...
2012 G/S Medical research; providing medical testing services and information in the field of cancer resea...